Loading…
Equilibrium distribution of HIV antiviral drugs into human peripheral blood mononuclear cells (PBMC) is controlled by free drug concentration in the extracellular medium
Effect of protein binding on the equilibrium distribution of selected HIV antiviral drugs into isolated human peripheral blood mononuclear cells (PBMC, mainly lymphocytes) was investigated. Human PBMC from a single healthy human donor were isolated, purified, and cryopreserved. Uptake of non-peptide...
Saved in:
Published in: | Journal of pharmaceutical and biomedical analysis 1999-03, Vol.19 (3), p.399-411 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c390t-ed3c11e5bf1e6f4e2626ec9670b41cdc324ce66bade6a7527e2170a23a5585f83 |
---|---|
cites | cdi_FETCH-LOGICAL-c390t-ed3c11e5bf1e6f4e2626ec9670b41cdc324ce66bade6a7527e2170a23a5585f83 |
container_end_page | 411 |
container_issue | 3 |
container_start_page | 399 |
container_title | Journal of pharmaceutical and biomedical analysis |
container_volume | 19 |
creator | Koeplinger, Kenneth A Raub, Thomas J Padbury, Guy E Zhao, Zhiyang |
description | Effect of protein binding on the equilibrium distribution of selected HIV antiviral drugs into isolated human peripheral blood mononuclear cells (PBMC, mainly lymphocytes) was investigated. Human PBMC from a single healthy human donor were isolated, purified, and cryopreserved. Uptake of non-peptide HIV-1 protease inhibitors PNU-96988 and PNU-103017 by these cells in vitro was evaluated as a function of increasing concentration of human serum in the cell incubation media. Both PNU-96988 and PNU-103017 were extensively bound to serum proteins. Uptake/efflux kinetics were very rapid such that accumulation by the cells was thermodynamically, not kinetically, controlled. Accumulation by human PBMCs in vitro was directly proportional to the free and not the total drug concentration in the media. For comparative purposes, the serum protein binding effect on the distribution of two HIV reverse transcriptase (RT) inhibitors, delavirdine (RESCRIPTOR) and zidovudine (AZT), was also evaluated. Like the HIV-1 protease inhibitors, delavirdine was found to be extensively associated with serum proteins and its accumulation by human PBMCs in vitro to be proportional to the free and not total drug concentration. In contrast, AZT was not bound to serum proteins to any significant extent. The uptake of this drug by human PBMCs in vitro was independent of serum concentration. However, the intrinsic cellular accumulation of PNU-96988, PNU-103017 and delavirdine were all greater than AZT. Thus, the extent to which drugs uptake by cells is affected by serum appears proportional to the binding affinity of the serum proteins for the drug. |
doi_str_mv | 10.1016/S0731-7085(98)00143-5 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69440203</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708598001435</els_id><sourcerecordid>69440203</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-ed3c11e5bf1e6f4e2626ec9670b41cdc324ce66bade6a7527e2170a23a5585f83</originalsourceid><addsrcrecordid>eNqFkd1u1DAQhS0EokvhEUC-QKi9CNhJ7CRXFawKrVQEEj_iznLsCWvk2Fv_VO0j8ZZ1dlfAHVeWZr45czwHoeeUvKaE8jdfSNfQqiM9Oxn6U0Jo21TsAVrRvmuqmrc_HqLVH-QIPYnxFyGE0aF9jI4o6UhLCVuh3-fX2VgzBpNnrE1MwYw5Ge-wn_DF5XcsXTI3JkiLdcg_IzYuebzJs3R4C8FsN7D0Ruu9xrN33mVlQQaswNqITz6_-7g-xSZi5V0K3lrQeLzDUwDYCS51BaUld0uNw2kDGG5LYVHItkjNoIu7p-jRJG2EZ4f3GH17f_51fVFdffpwuX57ValmIKkC3ShKgY0TBT61UPOagxp4R8aWKq2aulXA-Sg1cNmxuoOadkTWjWSsZ1PfHKNXe91t8NcZYhKziYsX6cDnKPjQtqQmTQHZHlTBxxhgEttgZhnuBCViyUjsMhJLAGLoxS4jwcrci8OCPJav_TO1D6UALw-AjEraKUinTPzLdbSkuGBnewzKNW4MBBGVgXJNbQKoJLQ3_3FyDxnssbY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69440203</pqid></control><display><type>article</type><title>Equilibrium distribution of HIV antiviral drugs into human peripheral blood mononuclear cells (PBMC) is controlled by free drug concentration in the extracellular medium</title><source>Elsevier</source><creator>Koeplinger, Kenneth A ; Raub, Thomas J ; Padbury, Guy E ; Zhao, Zhiyang</creator><creatorcontrib>Koeplinger, Kenneth A ; Raub, Thomas J ; Padbury, Guy E ; Zhao, Zhiyang</creatorcontrib><description>Effect of protein binding on the equilibrium distribution of selected HIV antiviral drugs into isolated human peripheral blood mononuclear cells (PBMC, mainly lymphocytes) was investigated. Human PBMC from a single healthy human donor were isolated, purified, and cryopreserved. Uptake of non-peptide HIV-1 protease inhibitors PNU-96988 and PNU-103017 by these cells in vitro was evaluated as a function of increasing concentration of human serum in the cell incubation media. Both PNU-96988 and PNU-103017 were extensively bound to serum proteins. Uptake/efflux kinetics were very rapid such that accumulation by the cells was thermodynamically, not kinetically, controlled. Accumulation by human PBMCs in vitro was directly proportional to the free and not the total drug concentration in the media. For comparative purposes, the serum protein binding effect on the distribution of two HIV reverse transcriptase (RT) inhibitors, delavirdine (RESCRIPTOR) and zidovudine (AZT), was also evaluated. Like the HIV-1 protease inhibitors, delavirdine was found to be extensively associated with serum proteins and its accumulation by human PBMCs in vitro to be proportional to the free and not total drug concentration. In contrast, AZT was not bound to serum proteins to any significant extent. The uptake of this drug by human PBMCs in vitro was independent of serum concentration. However, the intrinsic cellular accumulation of PNU-96988, PNU-103017 and delavirdine were all greater than AZT. Thus, the extent to which drugs uptake by cells is affected by serum appears proportional to the binding affinity of the serum proteins for the drug.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/S0731-7085(98)00143-5</identifier><identifier>PMID: 10704105</identifier><identifier>CODEN: JPBADA</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adult ; AIDS/HIV ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral ; Antiviral agents ; Biological and medical sciences ; Biological Transport - drug effects ; Blood Proteins - pharmacology ; Cells, Cultured ; Cryopreservation ; Delavirdine - pharmacokinetics ; Dose-Response Relationship, Drug ; Equilibrium distribution ; Extracellular Space - metabolism ; HIV ; HIV Protease Inhibitors - pharmacokinetics ; Humans ; Leukocytes, Mononuclear - cytology ; Leukocytes, Mononuclear - drug effects ; Leukocytes, Mononuclear - metabolism ; Male ; Medical sciences ; Peripheral blood mononuclear cell ; Pharmacology. Drug treatments ; Protein Binding ; Pyrones - pharmacokinetics ; Reverse Transcriptase Inhibitors - pharmacokinetics ; Sulfonamides - pharmacokinetics ; Tissue Distribution ; Uptake ; Zidovudine - pharmacokinetics</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 1999-03, Vol.19 (3), p.399-411</ispartof><rights>1999 Elsevier Science B.V.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-ed3c11e5bf1e6f4e2626ec9670b41cdc324ce66bade6a7527e2170a23a5585f83</citedby><cites>FETCH-LOGICAL-c390t-ed3c11e5bf1e6f4e2626ec9670b41cdc324ce66bade6a7527e2170a23a5585f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1711945$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10704105$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koeplinger, Kenneth A</creatorcontrib><creatorcontrib>Raub, Thomas J</creatorcontrib><creatorcontrib>Padbury, Guy E</creatorcontrib><creatorcontrib>Zhao, Zhiyang</creatorcontrib><title>Equilibrium distribution of HIV antiviral drugs into human peripheral blood mononuclear cells (PBMC) is controlled by free drug concentration in the extracellular medium</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>Effect of protein binding on the equilibrium distribution of selected HIV antiviral drugs into isolated human peripheral blood mononuclear cells (PBMC, mainly lymphocytes) was investigated. Human PBMC from a single healthy human donor were isolated, purified, and cryopreserved. Uptake of non-peptide HIV-1 protease inhibitors PNU-96988 and PNU-103017 by these cells in vitro was evaluated as a function of increasing concentration of human serum in the cell incubation media. Both PNU-96988 and PNU-103017 were extensively bound to serum proteins. Uptake/efflux kinetics were very rapid such that accumulation by the cells was thermodynamically, not kinetically, controlled. Accumulation by human PBMCs in vitro was directly proportional to the free and not the total drug concentration in the media. For comparative purposes, the serum protein binding effect on the distribution of two HIV reverse transcriptase (RT) inhibitors, delavirdine (RESCRIPTOR) and zidovudine (AZT), was also evaluated. Like the HIV-1 protease inhibitors, delavirdine was found to be extensively associated with serum proteins and its accumulation by human PBMCs in vitro to be proportional to the free and not total drug concentration. In contrast, AZT was not bound to serum proteins to any significant extent. The uptake of this drug by human PBMCs in vitro was independent of serum concentration. However, the intrinsic cellular accumulation of PNU-96988, PNU-103017 and delavirdine were all greater than AZT. Thus, the extent to which drugs uptake by cells is affected by serum appears proportional to the binding affinity of the serum proteins for the drug.</description><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>Biological Transport - drug effects</subject><subject>Blood Proteins - pharmacology</subject><subject>Cells, Cultured</subject><subject>Cryopreservation</subject><subject>Delavirdine - pharmacokinetics</subject><subject>Dose-Response Relationship, Drug</subject><subject>Equilibrium distribution</subject><subject>Extracellular Space - metabolism</subject><subject>HIV</subject><subject>HIV Protease Inhibitors - pharmacokinetics</subject><subject>Humans</subject><subject>Leukocytes, Mononuclear - cytology</subject><subject>Leukocytes, Mononuclear - drug effects</subject><subject>Leukocytes, Mononuclear - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Peripheral blood mononuclear cell</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Binding</subject><subject>Pyrones - pharmacokinetics</subject><subject>Reverse Transcriptase Inhibitors - pharmacokinetics</subject><subject>Sulfonamides - pharmacokinetics</subject><subject>Tissue Distribution</subject><subject>Uptake</subject><subject>Zidovudine - pharmacokinetics</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkd1u1DAQhS0EokvhEUC-QKi9CNhJ7CRXFawKrVQEEj_iznLsCWvk2Fv_VO0j8ZZ1dlfAHVeWZr45czwHoeeUvKaE8jdfSNfQqiM9Oxn6U0Jo21TsAVrRvmuqmrc_HqLVH-QIPYnxFyGE0aF9jI4o6UhLCVuh3-fX2VgzBpNnrE1MwYw5Ge-wn_DF5XcsXTI3JkiLdcg_IzYuebzJs3R4C8FsN7D0Ruu9xrN33mVlQQaswNqITz6_-7g-xSZi5V0K3lrQeLzDUwDYCS51BaUld0uNw2kDGG5LYVHItkjNoIu7p-jRJG2EZ4f3GH17f_51fVFdffpwuX57ValmIKkC3ShKgY0TBT61UPOagxp4R8aWKq2aulXA-Sg1cNmxuoOadkTWjWSsZ1PfHKNXe91t8NcZYhKziYsX6cDnKPjQtqQmTQHZHlTBxxhgEttgZhnuBCViyUjsMhJLAGLoxS4jwcrci8OCPJav_TO1D6UALw-AjEraKUinTPzLdbSkuGBnewzKNW4MBBGVgXJNbQKoJLQ3_3FyDxnssbY</recordid><startdate>19990301</startdate><enddate>19990301</enddate><creator>Koeplinger, Kenneth A</creator><creator>Raub, Thomas J</creator><creator>Padbury, Guy E</creator><creator>Zhao, Zhiyang</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990301</creationdate><title>Equilibrium distribution of HIV antiviral drugs into human peripheral blood mononuclear cells (PBMC) is controlled by free drug concentration in the extracellular medium</title><author>Koeplinger, Kenneth A ; Raub, Thomas J ; Padbury, Guy E ; Zhao, Zhiyang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-ed3c11e5bf1e6f4e2626ec9670b41cdc324ce66bade6a7527e2170a23a5585f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>Biological Transport - drug effects</topic><topic>Blood Proteins - pharmacology</topic><topic>Cells, Cultured</topic><topic>Cryopreservation</topic><topic>Delavirdine - pharmacokinetics</topic><topic>Dose-Response Relationship, Drug</topic><topic>Equilibrium distribution</topic><topic>Extracellular Space - metabolism</topic><topic>HIV</topic><topic>HIV Protease Inhibitors - pharmacokinetics</topic><topic>Humans</topic><topic>Leukocytes, Mononuclear - cytology</topic><topic>Leukocytes, Mononuclear - drug effects</topic><topic>Leukocytes, Mononuclear - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Peripheral blood mononuclear cell</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Binding</topic><topic>Pyrones - pharmacokinetics</topic><topic>Reverse Transcriptase Inhibitors - pharmacokinetics</topic><topic>Sulfonamides - pharmacokinetics</topic><topic>Tissue Distribution</topic><topic>Uptake</topic><topic>Zidovudine - pharmacokinetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koeplinger, Kenneth A</creatorcontrib><creatorcontrib>Raub, Thomas J</creatorcontrib><creatorcontrib>Padbury, Guy E</creatorcontrib><creatorcontrib>Zhao, Zhiyang</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koeplinger, Kenneth A</au><au>Raub, Thomas J</au><au>Padbury, Guy E</au><au>Zhao, Zhiyang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Equilibrium distribution of HIV antiviral drugs into human peripheral blood mononuclear cells (PBMC) is controlled by free drug concentration in the extracellular medium</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>1999-03-01</date><risdate>1999</risdate><volume>19</volume><issue>3</issue><spage>399</spage><epage>411</epage><pages>399-411</pages><issn>0731-7085</issn><eissn>1873-264X</eissn><coden>JPBADA</coden><abstract>Effect of protein binding on the equilibrium distribution of selected HIV antiviral drugs into isolated human peripheral blood mononuclear cells (PBMC, mainly lymphocytes) was investigated. Human PBMC from a single healthy human donor were isolated, purified, and cryopreserved. Uptake of non-peptide HIV-1 protease inhibitors PNU-96988 and PNU-103017 by these cells in vitro was evaluated as a function of increasing concentration of human serum in the cell incubation media. Both PNU-96988 and PNU-103017 were extensively bound to serum proteins. Uptake/efflux kinetics were very rapid such that accumulation by the cells was thermodynamically, not kinetically, controlled. Accumulation by human PBMCs in vitro was directly proportional to the free and not the total drug concentration in the media. For comparative purposes, the serum protein binding effect on the distribution of two HIV reverse transcriptase (RT) inhibitors, delavirdine (RESCRIPTOR) and zidovudine (AZT), was also evaluated. Like the HIV-1 protease inhibitors, delavirdine was found to be extensively associated with serum proteins and its accumulation by human PBMCs in vitro to be proportional to the free and not total drug concentration. In contrast, AZT was not bound to serum proteins to any significant extent. The uptake of this drug by human PBMCs in vitro was independent of serum concentration. However, the intrinsic cellular accumulation of PNU-96988, PNU-103017 and delavirdine were all greater than AZT. Thus, the extent to which drugs uptake by cells is affected by serum appears proportional to the binding affinity of the serum proteins for the drug.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>10704105</pmid><doi>10.1016/S0731-7085(98)00143-5</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0731-7085 |
ispartof | Journal of pharmaceutical and biomedical analysis, 1999-03, Vol.19 (3), p.399-411 |
issn | 0731-7085 1873-264X |
language | eng |
recordid | cdi_proquest_miscellaneous_69440203 |
source | Elsevier |
subjects | Adult AIDS/HIV Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral Antiviral agents Biological and medical sciences Biological Transport - drug effects Blood Proteins - pharmacology Cells, Cultured Cryopreservation Delavirdine - pharmacokinetics Dose-Response Relationship, Drug Equilibrium distribution Extracellular Space - metabolism HIV HIV Protease Inhibitors - pharmacokinetics Humans Leukocytes, Mononuclear - cytology Leukocytes, Mononuclear - drug effects Leukocytes, Mononuclear - metabolism Male Medical sciences Peripheral blood mononuclear cell Pharmacology. Drug treatments Protein Binding Pyrones - pharmacokinetics Reverse Transcriptase Inhibitors - pharmacokinetics Sulfonamides - pharmacokinetics Tissue Distribution Uptake Zidovudine - pharmacokinetics |
title | Equilibrium distribution of HIV antiviral drugs into human peripheral blood mononuclear cells (PBMC) is controlled by free drug concentration in the extracellular medium |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T11%3A24%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Equilibrium%20distribution%20of%20HIV%20antiviral%20drugs%20into%20human%20peripheral%20blood%20mononuclear%20cells%20(PBMC)%20is%20controlled%20by%20free%20drug%20concentration%20in%20the%20extracellular%20medium&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Koeplinger,%20Kenneth%20A&rft.date=1999-03-01&rft.volume=19&rft.issue=3&rft.spage=399&rft.epage=411&rft.pages=399-411&rft.issn=0731-7085&rft.eissn=1873-264X&rft.coden=JPBADA&rft_id=info:doi/10.1016/S0731-7085(98)00143-5&rft_dat=%3Cproquest_cross%3E69440203%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c390t-ed3c11e5bf1e6f4e2626ec9670b41cdc324ce66bade6a7527e2170a23a5585f83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69440203&rft_id=info:pmid/10704105&rfr_iscdi=true |